Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001873725 | SCV002120381 | uncertain significance | Chromosome 2q32-q33 deletion syndrome | 2022-06-27 | criteria provided, single submitter | clinical testing | This missense change has been observed in individual(s) with anencephaly (PMID: 31849593). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SATB2 protein function. ClinVar contains an entry for this variant (Variation ID: 1174112). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 532 of the SATB2 protein (p.Arg532Cys). |
Gene |
RCV003328679 | SCV004035820 | uncertain significance | not provided | 2023-03-27 | criteria provided, single submitter | clinical testing | De novo variant with confirmed parentage in a patient with craniorachischisis in published literature (Wang et al., 2019); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31849593) |
Centre de Biologie Pathologie Génétique, |
RCV001527649 | SCV001738762 | uncertain significance | Global developmental delay | 2020-01-01 | no assertion criteria provided | clinical testing |